Primary Record
cyclosporin A
- In stock
- 6,250 g
- Purity
- 98.4 %
- CAS
- 59865-13-3
Compound Identifiers & Properties
- CAS
- 59865-13-3
- PubChem CID
- 5284373
- SMILES
- CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
- Canonical SMILES
- C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
Names & Synonyms
- cyclosporin A
- cyclosporine
- Ciclosporin
- Cyclosporin
- Sandimmune
- Cyclosporine A
- Neoral
- Sandimmun
- Ciclosporine
- Neoplanta
- Restasis
- Equoral
- Gengraf
- Ramihyphin A
- Ciclosporina
- Ciclosporinum
- Ciclosporin A
- Consupren
- Optimmune
- Mitogard
- Atopica
- 59865-13-3
- Sandimmun Neoral
- Zinograf ME
- SangCyA
- NeuroSTAT
- Papilock Mini
- Sang-35
- Abrammune
- Cicloral
- Imusporin
- Ikervis
- Seciera
- Vekacia
- S-Neoral
- Cipol N
- CsANeoral
- Cyclavance
- Cyclospori
- Sigmasporin
- Arpimune ME
- Capimune
- Capsorin
- Cicporal
- Cyclokat
- Deximune
- Neomerck
- Papilock
- Pleiabil
- Pulminiq
- Sporimune
- Vanquoral
- Zyclorin
- Amadra
- CicloMulsion
- CyclosporinA
- Sandimmune Neoral
- CsA Neoral
- Cyclosporine;
- Ciclosporin;
- Ciclosporina A
- Cyclosporine-A
- Cyclosporin H
- Sandimmun;
- Ciclosporin DT
- Ciclosporin RS
- Cyclorin;
- Consupren S
- VEVYE
- Ciclosporin CRS
- Ciclosporina Germed
- Antibiotic S 7481F1
- Modusik-A
- Neoral;
- Iodocyclosporin A
- Ramihyphin A;
- CsA-Neoral
- Cyclosporine, modified
- Atopica for Cats
- Modulis for Cats
- Modulis for Dogs
- Ciclosporin [INN]
- 1cyn
- 2wfj
- 4jjm
- Cipol-N
- Sigmasporin Microoral
- CEQUA
- Restasis MultiDose
- Sang 35
- VERKAZIA
- ,32-undecaone
- Neoral, Sandimmune
- CyA NOF
- CyA-NOF
- Debio088
- Cicloral (antibiotic)
- Cyclosporine [USAN]
- Prestwick_731
- Optimmune Ophthalmic
- Cyclosporine microemulsion
- Ciclosporine [INN]
- Cyclosporine Modified
- Cyclosporin A solution
- CsA & IFN.alpha.
- 83HN0GTJ6D
- Cyclosporine/Ciclosporin
- Cyclosporine;Ciclosporin
- 1c5f
- 2z6w
- ANTIBIOTIC S-7481F1
- Cyclosporine [USAN:USP]
- CycloSPORINE, Modfied
- Cyclosporine manufacturer
- UNII-83HN0GTJ6D
- Ciclosporine [INN-French]
- Ciclosporinum [INN-Latin]
- DTXSID0020365
- SDZ-OXL-400
- Ciclosporina [INN-Spanish]
- Prestwick2_000435
- Prestwick3_000435
- RefChem:919442
- CHEBI:4031
- CICLOSPORIN [JAN]
- Cyclosporin A (Standard)
- Cyclosporine A/B/C/D/H
- MFCD00274558
- CHEMBL160
- DTXCID00365
- Epitope ID:451241
- Sang-2000
- SDZ-OXL 400
- CYCLOSPORINE [HSDB]
- CYCLOSPORINE [IARC]
- Cyclosporine/Chondroitin PF
- AC1NR4C4
- CYCLOSPORIN A [MI]
- MLS001333756
- SCHEMBL4442
- CCRIS 1590
- PMATZTZNYRCHOR-CGLBZJNRSA-N
- CICLOSPORIN [MART.]
- CYCLOSPORINE [VANDF]
- Nova-22007
- Ikervis (opthalmic solution)
- BSPBio_000450
- CICLOSPORIN [WHO-DD]
- CICLOSPORIN [WHO-IP]
- C62H111N11O12
- Cyclosporin A & IFN.alpha.
- HSDB 6881
- MLS000028376
- MLS002153454
- MLS002207033
- Verkazia (opthalmic solution)
- CYCLOSPORINE [USP-RS]
- cyclosporine ophthalmic solution
- BPBio1_000496
- GTPL1024
- orb1310145
- DRG-0275
- NSC-290193
- CHEBI:92233
- ERK5-2D14
- HY-B0579R
- AOB2581
- ATH-002
- CYCLOSPORINE [GREEN BOOK]
- L04AD01
- OL 27-400
- OL-27-400
- OLO-400
- S01XA18
- CB-01-09 MMX
- NSC290193
- CICLOSPORIN [EP MONOGRAPH]
- CYCLOSPORINE [ORANGE BOOK]
- GLXC-04692
- GLXC-06801
- HMS1569G12
- HMS2089A09
- HMS2096G12
- HMS2230M14
- HMS3713G12
- S 7481F1
- Cyclosporin A - Bio-X trade mark
- CYCLOSPORINE [USP IMPURITY]
- NSC 290193
- Cyclosporin A, Ready Made Solution
- Cyclosporine/Chondroitin Sulfate PF
- EX-A4110
- HY-B0579
- MSK10250
- CYCLOSPORINE [USP MONOGRAPH]
- Tox21_110667
- Tox21_301849
- 9-(N-Methyl-L-valine)cyclosporin A
- BDBM50022815
- CICLOSPORINUM [WHO-IP LATIN]
- DE-076
- EBC-27538
- ST-603
- Cyclosporin A, >=98.5% (TLC)
- OL 27400
- AKOS015969287
- AKOS015994720
- Tox21_110667_1
- ACN-029253
- BAT-010028
- CCG-208184
- CID5284373
- CS-2761
- CS-O-06250
- DB00091
- EBD2126862
- FC20749
- KS-1257
- OL 27 400
- SDCCGSBI-0050230.P004
- CID:5284373
- NCGC00016890-01
- NCGC00093704-12
- NCGC00164258-01
- NCGC00164258-02
- NCGC00164258-03
- NCGC00255232-01
- AT-12519
- BC164336
- BP-28432
- C042
- Ciclosporin (Cyclosporin A; Cyclosporine)
- J34.321H
- OL-27400
- SID:53787388
- SMR000058578
- SY012000
- C62-H111-N11-O12
- SBI-0050230.P003
- AB0090560
- CAS-59865-13-3
- CSA
- HY-100731
- B1922
- C2408
- 5946-EP0930075A1
- 5946-EP2289877A1
- 5946-EP2292601A1
- 5946-EP2292602A1
- 5946-EP2292603A1
- 5946-EP2292604A2
- 5946-EP2292618A1
- 5946-EP2293650A1
- 5946-EP2298737A1
- 5946-EP2298739A1
- 5946-EP2298740A1
- 5946-EP2298741A1
- 5946-EP2298771A2
- 5946-EP2301920A1
- 5946-EP2301940A1
- 5946-EP2308843A1
- 5946-EP2308861A1
- A10260
- J10181
- J90049
- M01532
- 79217-60-0
- 865C133
- A832514
- Cyclosporin A, VETRANAL(TM), analytical standard
- D016572
- Q367700
- SR-01000780563
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA
- BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA
- SR-01000780563-3
- BRD-K03222093-001-01-8
- BRD-K13533483-001-03-0
- Ciclosporin, European Pharmacopoeia (EP) Reference Standard
- Cyclosporin A, 99%, an immunosuppressive agent - 1G 1g
- (R-(R*,R*-(E)))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)
- -undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29
- Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl)
- 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptide deriv.
- Cyclosporin A, from Tolypocladium inflatum, >=95% (HPLC), solid
- Cyclosporine, United States Pharmacopeia (USP) Reference Standard
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- CYA
- Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)
- 9,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
- Ciclosporin for system suitability, European Pharmacopoeia (EP) Reference Standard
- Cyclosporin A, from Tolypocladium inflatum, BioReagent, for molecular biology, >=95%
- Cyclosporine, Pharmaceutical Secondary Standard; Certified Reference Material
- (3R,4R)-3-Hydroxy-N-methyl-5-[(E)-1-propenyl]-cyclo(L-Leu-L-Abu-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-)
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,1
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((E,1R,2R)-1-hydroxy-2-methylhex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-Ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,2
- (R-(R*,R*-(E)))-CYCLIC(L-ALANYL-D-ALANYL-N-METHYL-L-LEUCYL-N-METHYL-L-LEUCYL-N-METHYL-L-VALYL-3-HYDROXY-N,4-DIMETHYL-L-2-AMINO-6-OCTENOYL-L-.ALPHA.-AMINOBUTYRYL-N-METHYLGLYCYL-N-METHYL-L-LEUCYL-L-VALYL-N-METHYL-L-LEUCYL)
- (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)
- 1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine]
- 104250-72-8
- 156047-28-8
- 30-Ethyl-33-((E)-1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
- 30-ethyl-33-((E)-1-hydroxy-2-methylhex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
- 30-ethyl-33-(1-hydroxy-2-methylhex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 55126-45-9
- 59865-14-4
- 611-907-1
- Ciclosporin; Cyclo[[(2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)oct-6-enoyl]-l-2-aminobutanoyl-N-methylglycyl-N-methyl-l-leucyl-l-valyl-N-methyl-l-leucyl-l-alanyl-d-alanyl-N-methyl-l-leucyl-N-methyl-l-leucyl-N-methyl-l-valyl]; ciclosporin A; 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptide deriv.; Abrammune; Antibiotic S 7481F1; Arpimune ME; CICPORAL; Cicloral; Cicloral (antibiotic); Ciclosporina Germed; Cipol N; Consupren; Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]; Cyclokat; Cyclosporin; Cyclosporine; Cyclosporine A; Debio088; Equoral; Gengraf; Imusporin; NSC 290193; Neoplanta; Neoral; OL 27-400; Optimmune; Papilock Mini; Ramihyphin A; Restasis; S-Neoral; SDZ-OXL 400; Sandimmun; Sa
- cyclo(-((2S,3R,4R,6E)-3-Hydroxy-4-methyl-2-methylaminooct-6-enoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-)
- Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)
- Cyclo[[(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl]